On the chart you can see the default numbers in dynamics for Huapont Life Sciences Co., Ltd. (002004.SZ). Companys revenue shows the average of 4719.527 M which is 0.415 % gowth. The average gross profit for the whole period is 1826.221 M which is 0.211 %. The average gross profit ratio is 0.518 %. The net income growth for the company last year performance is -0.732 % which equals 0.246 % % on average for the whole company history.,
Diving into the fiscal trajectory of Huapont Life Sciences Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.023. In the realm of current assets, 002004.SZ clocks in at 11387.4 in the reporting currency. A significant portion of these assets, precisely 4413.135, is held in cash and short-term investments. This segment shows a change of -0.098% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 2253.482, if any, in the reporting currency. This indicates a difference of 0.870% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 2932.089 in the reporting currency. This figure signifies a year_over_year change of 0.072%. Shareholder value, as depicted by the total shareholder equity, is valued at 10105.177 in the reporting currency. The year over year change in this aspect is -0.009%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 2844.748, with an inventory valuation of 2674.61, and goodwill valued at 2739.93, if any. The total intangible assets, if present, are valued at 1652.44. Account payables and short-term debt are 2702.85 and 5693.76, respectively. The total debt is 8625.84, with a net debt of 4842.99. Other current liabilities amount to 29.69, adding to the total liabilities of 14142.66. Lastly, the referred stock is valued at 84.95, if it exists.
The financial landscape of Huapont Life Sciences Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.761. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 1.46 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -556492650.870 in the reporting currency. This is a shift of -0.296 from the previous year. In the same period, the company recorded 800.23, -176.39, and -7897.82, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -854.41 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 7381.97, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.
Huapont Life Sciences Co., Ltd.'s revenue saw a change of -0.124% compared with the previous period. The gross profit of 002004.SZ is reported to be 4535.07. The company's operating expenses are 3032.17, showing a change of -9.489% from the last year. The expenses for depreciation and amortization are 800.23, which is a 0.114% change from the last accounting period. Operating expenses are reported to be 3032.17, which shows a -9.489% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.651% year-over-year growth. The operating income is 926.51, which shows a -0.651% change when compared to the previous year. The change in the net income is -0.732%. The net income for the last year was 302.12.
